Australia has one of the highest rates of depression worldwide, with 5.9% of the population--or over 1.3 million individuals—affected in 2022. Symptoms include loss of interest in activities, feelings of worthlessness and hopelessness, and insomnia.
If you’re between the ages of 18-65 and your antidepressant isn’t working well enough to alleviate your symptoms, know your options. Right now, local doctors are conducting research studies to evaluate add-on, investigational medication to take with (not instead of) your current antidepressant.
For yourself, for those you love, and for future generations, please consider volunteering for clinical trials. Join the fight against MDD. Together, we could help change lives.
Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.